| HOME >> BIOLOGY >> TECHNOLOGY |
- Sales Up 9%
- Non-GAAP and GAAP Operating Earnings Up 6%
- Non-GAAP Diluted EPS Up 15%, GAAP Diluted EPS Up 16%
PALO ALTO, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today reported first quarter 2008 revenues of $237.4 million, representing an increase of 8.9% over revenues of $217.9 million in the first quarter of fiscal year 2007. The increase was broad-based, with growth in sales of products for both life science and industrial (which includes environmental, food and energy) applications. Sales increased in all geographic regions, with particularly strong sales growth in Asia Pacific and Latin America.
Non-GAAP (adjusted) net earnings for the first quarter of fiscal year 2008 increased 13.8% to $21.5 million, or $0.70 diluted earnings per share, compared to $18.9 million, or $0.61 diluted earnings per share, in the first quarter of fiscal year 2007. On a GAAP basis, net earnings in the first quarter of fiscal year 2008 were $17.6 million, or $0.57 diluted earnings per share, compared to $15.4 million, or $0.49 diluted earnings per share, in the first quarter of fiscal year 2007.
Adjusted operating earnings increased 6.1% to $30.1 million in the
first quarter of fiscal year 2008, compared to $28.4 million in the first
quarter last year. Adjusted operating profit margin was 12.7% in the first
quarter of fiscal year 2008, compared to 13.0% in the prior-year quarter.
This decrease was primarily due to lower adjusted operating margins in the
Vacuum Technologies segment in the current quarter compared to unusually
strong results in the year-ago quarter. In addition, the sales growth in
the first quarter of fiscal year 2008 was entirely attributable to the
Scientific Instruments segment, which has lower adjusted operating margins
than the Vacuum Technologies segment. On a GAAP basis, operating earnings
were $24.1 million and operating profit margin was 10
'/>"/>
| SOURCE Varian, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |